Cardiac Niche Influences the Direct Reprogramming of Canine Fibroblasts into Cardiomyocyte-Like Cells

Stem Cells International

Volumn 2016, Issue , 2016, Pages

  Palazzolo, Giacomo ^a,b   Quattrocelli, Mattia ^a   Toelen, Jaan ^a   Dominici, Roberto ^c   Anastasia, Luigi ^b,d   Tettamenti, Guido ^b   Barthelemy, Inès ^e   Blot, Stephane ^e   Gijsbers, Rik ^f   Cassano, Marco ^g   Sampaolesi, Maurilio ^a,h  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

^c Ospedale di Magenta   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^f DEPARTMENT OF PHARMACEUTICAL AND PHARMACOLOGICAL SCIENCES   (Belgium)

^g EPFL   (Switzerland)

^h UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; PROTEIN HAND2; PROTEIN MEF2C; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR TBX5; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; GOLDEN RETRIEVER; HEART DEVELOPMENT; HEART FIBROBLAST; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MOUSE; NEWBORN; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; SCID BEIGE MOUSE; SKIN FIBROBLAST; SOMATIC CELL; VIRAL GENE DELIVERY SYSTEM;

EID: 84949238524     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2016/4969430     Document Type: Article

References (36)

1. S. A. Doppler, M.-A. Deutsch, R. Lange, and M. Krane, "Cardiac regeneration: current therapies-future concepts, " Journal of Thoracic Disease, vol. 5, no. 5, pp. 683-697, 2013.
2. A. B. Carvalho and A. C. deCarvalho, "Heart regeneration: past, present and future, " World Journal of Cardiology, vol. 2, no. 5, pp. 107-111, 2010.
3. R. D. Brown, S. K. Ambler, M. D. Mitchell, and C. S. Long, "The cardiac fibroblast: Therapeutic target in myocardial remodeling and failure, " Annual Review of Pharmacology and Toxicology, vol. 45, pp. 657-687, 2005.
4. J. L. Ifkovits, R. C. Addis, J. A. Epstein, and J. D. Gearhart, "Inhibition of TGF signaling increases direct conversion of fibroblasts to induced cardiomyocytes, " PLoS ONE, vol. 9, no. 2, Article ID e89678, 2014.
5. R. L. Davis, H. Weintraub, and A. B. Lassar, "Expression of a single transfected cDNAconverts fibroblasts tomyoblasts, " Cell, vol. 51, no. 6, pp. 987-1000, 1987.
6. M. Ieda, J.-D. Fu, P. Delgado-Olguin et al., "Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors, " Cell, vol. 142, no. 3, pp. 375-386, 2010.
7. N. Christoforou, M. Chellappan, A. F. Adler et al., "Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming, " PLoS ONE, vol. 8, no. 5, Article ID e63577, 2013.
8. T. M. Jayawardena, B. Egemnazarov, E. A. Finch et al., "MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes, " Circulation Research, vol. 110, no. 11, pp. 1465-1473, 2012.
9. S. Protze, S. Khattak, C. Poulet, D. Lindemann, E. M. Tanaka, and U. Ravens, "A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells, " Journal of Molecular and Cellular Cardiology, vol. 53, no. 3, pp. 323-332, 2012.
10. K. Song, Y.-J. Nam, X. Luo et al., "Heart repair by reprogramming non-myocytes with cardiac transcription factors, " Nature, vol. 485, no. 7400, pp. 599-604, 2012.
11. K. Inagawa, K. Miyamoto, H. Yamakawa et al., "Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5, " Circulation Research, vol. 111, no. 9, pp. 1147-1156, 2012.
12. L. Qian, Y. Huang, C. I. Spencer et al., "In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes, " Nature, vol. 485, no. 7400, pp. 593-598, 2012.
13. J.-D. Fu, N. R. Stone, L. Liu et al., "Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state, " Stem Cell Reports, vol. 1, no. 3, pp. 235-247, 2013.
14. Y.-J. Nam, K. Song, X. Luo et al., "Reprogramming of human fibroblasts toward a cardiac fate, " Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 14, pp. 5588-5593, 2013.
15. J. Finsterer and C. Stöllberger, "The heart in human dystrophinopathies, " Cardiology, vol. 99, no. 1, pp. 1-19, 2003.
16. F. Muntoni, S. Torelli, and A. Ferlini, "Dystrophin and mutations: one gene, several proteins, multiple phenotypes, " The Lancet Neurology, vol. 2, no. 12, pp. 731-740, 2003.
17. D. Townsend, S. Yasuda, J. Chamberlain, and J. M. Metzger, "Cardiac consequences to skeletal muscle-centric therapeutics for Duchenne muscular dystrophy, " Trends in Cardiovascular Medicine, vol. 19, no. 2, pp. 50-55, 2009.
18. K. A. Frankel and R. J. Rosser, "The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis, " Human Pathology, vol. 7, no. 4, pp. 375-386, 1976.
19. G. B. Banks and J. S. Chamberlain, "The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies, " Current Topics in Developmental Biology, vol. 84, pp. 431-453, 2008.
20. J. M. Howell, S. Fletcher, B. A. Kakulas, M. O'Hara, H. Lochmuller, and G. Karpati, "Use of the dog model for Duchennemuscular dystrophy in gene therapy trials, " Neuromuscular Disorders, vol. 7, no. 5, pp. 325-328, 1997.
21. J. N. Kornegay, S. M. Tuler, D. M. Miller, and D. C. Levesque, "Muscular dystrophy in a litter of golden retriever dogs, " Muscle and Nerve, vol. 11, no. 10, pp. 1056-1064, 1988.
22. V. Chetboul, C. Escriou, D. Tessier et al., "Tissue Doppler imaging detects early asymptomatic myocardial abnormalities in a dog model of Duchenne's cardiomyopathy, " European Heart Journal, vol. 25, no. 21, pp. 1934-1939, 2004.
23. N. S. Moise, B. A. Valentine, C. A. Brown et al., "Duchenne's cardiomyopathy in a canine model: electrocardiographic and echocardiographic studies, " Journal of theAmericanCollege of Cardiology, vol. 17, no. 3, pp. 812-820, 1991.
24. B. A. Valentine, J. F. Cummings, and B. J. Cooper, "Development of Duchenne-type cardiomyopathy. Morphologic studies in a canine model, " The American Journal of Pathology, vol. 135, no. 4, pp. 671-678, 1989.
25. T. Walcher, M. Kunze, P. Steinbach et al., "Cardiac involvement in a female carrier of Duchenne muscular dystrophy, " International Journal of Cardiology, vol. 138, no. 3, pp. 302-305, 2010.
26. C. Torre, I. Jeusette, M. Serra, P. Brazis, and A. Puigdemont, "Bovine colostrum increases proliferation of canine skin fibroblasts, " Journal of Nutrition, vol. 136, no. 7, supplement, pp. 2058S-2060S, 2006.
27. M. Caiazzo, M. T. Dell'Anno, E. Dvoretskova et al., "Direct generation of functional dopaminergic neurons from mouse and human fibroblasts, " Nature, vol. 476, no. 7359, pp. 224-227, 2011.
28. P. Huang, Z. He, S. Ji et al., "Induction of functional hepatocytelike cells frommouse fibroblasts by defined factors, " Nature, vol. 475, no. 7356, pp. 386-391, 2011.
29. P. Huang, L. Zhang, Y. Gao et al., "Direct reprogramming of human fibroblasts to functional and expandable hepatocytes, " Cell Stem Cell, vol. 14, no. 3, pp. 370-384, 2014.
30. S. Sekiya andA. Suzuki, "Direct conversion ofmouse fibroblasts to hepatocyte-like cells by defined factors, " Nature, vol. 475, no. 7356, pp. 390-393, 2011.
31. Q. Zhou, J. Brown, A. Kanarek, J. Rajagopal, and D. A. Melton, "In vivo reprogramming of adult pancreatic exocrine cells to beta-cells, " Nature, vol. 455, no. 7213, pp. 627-632, 2008.
32. M. Cassano, E. Berardi, S. Crippa et al., "Alteration of cardiac progenitor cell potency in GRMD dogs, " Cell Transplantation, vol. 21, no. 9, pp. 1945-1967, 2012.
33. D. P. Judge, D. A. Kass, W. R. Thompson, and K. R. Wagner, "Pathophysiology and therapy of cardiac dysfunction in Duchenne muscular dystrophy, "The American Journal of Cardiovascular Drugs, vol. 11, no. 5, pp. 287-294, 2011.
34. L. Qian, E. C. Berry, J.-D. Fu, M. Ieda, and D. Srivastava, "Reprogramming of mouse fibroblasts into cardiomyocyte-like cells in vitro, " Nature Protocols, vol. 8, no. 6, pp. 1204-1215, 2013.
35. Y.-J. Nam, C. Lubczyk, M. Bhakta et al., "Induction of diverse cardiac cell types by reprogramming fibroblasts with cardiac transcription factors, " Development (Cambridge), vol. 141, no. 22, pp. 4267-4278, 2014.
36. L. Wang, Z. Liu, C. Yin et al., "Stoichiometry of Gata4, Mef2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming, " Circulation Research, vol. 116, no. 2, pp. 237-244, 2015.